Mesoblast Limited revenue for the last year amounted to 5.90 M USD, the most of which — 5.90 M USD — came from its highest performing source at the moment, Cell Technology Platform, the year earlier bringing 7.50 M USD. The greatest contribution to the revenue figure was made by Australia, United States, Singapore, United Kingdom and Switzerland — last year it brought Mesoblast Limited 5.90 M USD, and the year before that — 7.50 M USD.